Cubist Systematic Strategies’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-32,400
Closed -$483K 3867
2023
Q4
$483K Sell
32,400
-34,700
-52% -$393K ﹤0.01% 2542
2023
Q3
$754K Buy
67,100
+12,600
+23% +$146K 0.01% 2065
2023
Q2
$548K Sell
54,500
-200,300
-79% -$1.86M ﹤0.01% 2335
2023
Q1
$2.4M Sell
254,800
-53,300
-17% -$629K 0.01% 1529
2022
Q4
$3.76M Buy
308,100
+263,800
+595% +$3.29M 0.02% 1287
2022
Q3
$550K Buy
+44,300
New +$774K ﹤0.01% 3092

Other funds holding ELAN

Cubist Systematic Strategies's ELAN Position: Q4 2024 in Review

Cubist Systematic Strategies sold out of Elanco Animal Health (ELAN) in Q4 2024, closing a stake of 48,252 shares — an estimated $709K sold.

Cubist Systematic Strategies first reported a position in ELAN in Q3 2018 and held it in 21 quarters. The position peaked at $18.3M in Q2 2021. 393 funds tracked by Wall St. Rank hold ELAN as of Q4 2024.

  • Cubist Systematic Strategies reported no remaining Elanco Animal Health position as of Q4 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 48,252 Elanco Animal Health shares in Q4 2024, an estimated $709K.
  • Cubist Systematic Strategies first reported a position in Elanco Animal Health in Q3 2018 and held it in 21 quarters.
  • Cubist Systematic Strategies's Elanco Animal Health position peaked at $18.3M in Q2 2021.
  • 393 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2024.

Based on Cubist Systematic Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.